Increased plasma soluble thrombomodulin levels in cardioembolic stroke

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 3, 2012, Pages 289-293

  Dharmasaroja, Permphan ^a   Dharmasaroja, Pornpatr A ^b   Sobhon, Prasert ^a  

^a Mahidol University   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

endothelial injury; stroke risk factor; stroke subtype

Indexed keywords

THROMBOMODULIN;

ADULT; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CORONARY ARTERY DISEASE; EMBOLISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE; THAILAND; THROMBOMODULIN;

EID: 84860755199     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611432744     Document Type: Article

References (24)

1. Takano S, Kimura S, Ohdama S, Aoki N.. Plasma thrombomodulin in health and diseases. Blood. 1990 ; 76 (10). 2024-2029
2. Weiler H, Isermann BH.. Thrombomodulin. J Thromb Haemost. 2003 ; 1 (7). 1515-1524
3. Salomaa V, Matei C, Aleksic N, et al. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis risk in communities. Atherosclerosis. 2001 ; 157 (2). 309-314 (Pubitemid 32710009)
4. Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R.. Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens Res. 2003 ; 26 (6). 479-483 (Pubitemid 36857067)
5. Nakagawa I, Matsubara T, Hori T, et al. Significance of soluble thrombomodulin in the coronary circulation of patients with coronary artery disease. J Cardiol. 2001 ; 38 (3). 145-152 (Pubitemid 32899641)
6. Zhang X, Hu Y, Hong M, Guo T, Wei W, Song S.. Plasma thrombomodulin, fibrinogen, and activity of tissue factor as risk factors for acute cerebral infarction. Am J Clin Pathol. 2007 ; 128 (2). 287-292 (Pubitemid 47262628)
7. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S.. Endothelial markers and adhesion molecules in acute ischemic stroke - sequential change and differences in stroke subtype. Atherosclerosis. 2002 ; 161 (1). 161-168 (Pubitemid 34214832)
8. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003 ; 126 (pt 2). 424-432 (Pubitemid 36172746)
9. Olivot JM, Labreuche J, Aiach M, Amarenco P.. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke. 2004 ; 35 (8). 1946-1951 (Pubitemid 38971881)
10. Nomura E, Kohriyama T, Kozuka K, Kajikawa H, Nakamura S, Matsumoto M.. Significance of serum soluble thrombomodulin level in acute cerebral infarction. Eur J Neurol. 2004 ; 11 (5). 329-334 (Pubitemid 38903566)
11. Moore DF, Li H, Jeffries N, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005 ; 111 (2). 212-221 (Pubitemid 40139734)
12. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR.. Association of serial biochemical markers with acute ischemic stroke: the national institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study. Stroke. 2006 ; 37 (10). 2508-2513 (Pubitemid 44454670)
13. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993 ; 24 (1). 35-41 (Pubitemid 23014379)
14. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 ; 20 (7). 864-870 (Pubitemid 19188240)
15. Takaya M, Ichikawa Y, Kobayashi N, et al. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1991 ; 9 (5). 495-499
16. Lindahl AK, Boffa MC, Abildgaard U.. Increased plasma thrombomodulin in cancer patients. Thromb Haemost. 1993 ; 69 (2). 112-114 (Pubitemid 23041178)
17. Morishita E, Saito M, Asakura H, et al. Increased levels of plasma thrombomodulin in chronic myelogenous leukemia. Am J Hematol. 1992 ; 39 (3). 183-187
18. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A.. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemostasis. 2009 ; 101 (5). 929-937
19. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol. 2009 ; 215 (1-2). 84-89
20. Wang L, Tran ND, Kittaka M, Fisher MJ, Schreiber SS, Zlokovic BV.. Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms. Arterioscler Thromb Vasc Biol. 1997 ; 17 (11). 3139-3146 (Pubitemid 28016069)
21. Wang L, Tran ND, Schreiber SS, Fisher M, Zlokovic BV.. Rat brain capillary thrombomodulin: structure and function. Thromb Res. 1998 ; 92 (5). 213-219 (Pubitemid 28545414)
22. Macko RF, Killewich LA, Fernandez JA, Cox DK, Gruber A, Griffin JH.. Brain-specific protein C activation during carotid artery occlusion in humans. Stroke. 1999 ; 30 (3). 542-545 (Pubitemid 29115389)
23. Li-Saw-Hee FL, Blann AD, Lip GY.. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol. 2000 ; 35 (7). 1926-1931 (Pubitemid 30342877)
24. Oida K, Takai H, Maeda H, et al. Plasma thrombomodulin concentration in diabetes mellitus. Diabetes Res Clin Pract. 1990 ; 10 (2). 193-196 (Pubitemid 20350542)